Drug Security Forum

The demand for public financing of medicines and other health technologies always exceeds the resources available across health systems, regardless of the country’s level of development. The problem dictates the need to choose the most effective medicines from a clinical and economic point of view within a limited budget. The Health Technology Assessment System (HTA) is a tool that allows to do it in a transparent and rational manner. This procedure is recognized as a tool for rational use of healthcare system funds in many countries. It has been a mandatory requirement for including medicines in the public financing system in the Russian Federation since 2014. The financial efficiency system by optimizing the choice of medicines needs to be constantly improved, taking into account the specifics of new technologies. Sharing best practices, knowledge, pooling the accumulated experience in this field contributes to more rational use of health systems. How to ensure the financial availability of drug therapy today? What are the limitations of the current HTA model for medicines? What further steps are required to improve current approaches to establishing restrictive lists of medicines? What are the approaches to HTA and procurement of innovative medicines? How should HTA and drug pricing be linked? Which areas of HTA should be prioritized for international cooperation and exchange of experiences?

Moderator
Vitaliy Omelyanovskiy, General Director, Center for Healthcare Quality Assessment and Control of the Ministry of Health of the Russian Federation

Vitaliy Omelyanovskiy

General Director, Center for Healthcare Quality Assessment and Control of the Ministry of Health of the Russian Federation

Born July 27, 1964 in Obninsk, Kaluga Oblast.
In 1987, he graduated from the Pirogov Russian National Research Medical University with a degree in General Medicine. After graduation he stayed in the university, where he rose from postgraduate to professor of the department of clinical pharmacology.
In 1998 he graduated from the Russian Presidential Academy of National Economy and Public Administration of the Russian Federation with a degree in state and municipal management, with the qualification of economist-financier.
In 2002, he defended the first doctoral dissertation in the Russian Federation on clinical and economic analysis and pharmacoeconomics.
From 2009 to 2012 he was. - Vladimir Potanin was Director of the Research Institute for Clinical and Economic Expertise and Pharmacoeconomics at the N.I. Pirogov Russian National Research Medical University, Federal State Autonomous Educational Institution of Higher Professional Education, Ministry of Health Care of the Russian Federation.
From 2012 to 2020, she was Head of the Research Laboratory of the N.I. Pirogov Russian National Research Medical University. - Head of the Research Laboratory for Technology Assessment in Healthcare at the Institute of Applied Economic Research of the Russian Presidential Academy of National Economy and Public Administration, a federal state budget-funded educational institution of higher education.
Since 2014. - Head of the Healthcare Finance Center of the Federal State Budgetary Institution "Research Financial Institute" of the Ministry of Finance of the Russian Federation. Ministry of Finance of the Russian Federation.
Since 2015. - General Director of the Federal State Budgetary Institution "Center for Expertise and Quality Control of Medical Care" of the Ministry of Health of the Russian Federation.
Since 2020. - Head of the Department of Economics, Management and Assessment of Healthcare Technologies of the Federal State Budgetary Educational Institution of Additional Professional Education "Russian Medical Academy of Continuing Professional Education" of the Ministry of Healthcare of the Russian Federation.

Member of the Dissertation Council D 208.088.01.
Head of the Expert Council on Health Care of the Federation Council Committee on Social Policy, Expert of the Analytical Centre for the Government of the Russian Federation.
Chief Clinical Pharmacologist, Ministry of Health, Moscow Region.
Chief editor of scientific journals, Pharmacoeconomics. Modern Pharmacoeconomics and Pharmacoepidemiology" and "Medical Technology. Evaluation and Choice".
She is an author of three patents of the Russian Federation, two monographs, educational and methodical manuals for physicians, and more than 140 scientific papers published in Russian and foreign medical journals.
Doctor of Medicine (2002), Professor (2007). Under his supervision V.V. Omelyanovsky defended one doctoral thesis and seven Ph. Currently supervises the theses of two doctoral students and two doctoral candidates.
He is the President of the Russian branch of the International Society for Pharmacoeconomic Research and Outcome Evaluation (ISPOR).
He is a laureate of the Russian Federation Government Award in Science and Technology, has certificates of merit from the President of the Russian Federation and the Chairman of the Federation Council of the Federal Assembly of the Russian Federation, and has received commendations from the Chairman of the Federation Council of the Federal Assembly of the Russian Federation, the Analytical Center of the Russian Federation Government, the Russian Academy of National Economy and Public Administration under the President of the Russian Federation, and the Sverdlovsk Oblast Government.

Panellists
Melita Vujnovic, Representative, World Health Organization Office in the Russian Federation
Anton Kugach, Head of the Department of Organization of Drug Supply, Ministry of Health of the Republic of Belarus
Elena Maksimkina, Director, "Federal Center for Planning and Regulation of Medical Supply Circulation" of the Ministry of Health of the Russian Federation
Oleg Malakhov, Chairman of the Board of Directors, PRIMEKEY Group of Companies; member of the General Council, All-Russian public organization "Business Russia"
Nuria Musina, Director of Development, Health Technology Assessment Association
Thi Thu Thuy Nguyen, Dean, Pharmacy Faculty, Hong Bang International University

Melita Vujnovic

Representative, World Health Organization Office in the Russian Federation

Anton Kugach

Head of the Department of Organization of Drug Supply, Ministry of Health of the Republic of Belarus

Elena Maksimkina

Director, "Federal Center for Planning and Regulation of Medical Supply Circulation" of the Ministry of Health of the Russian Federation

She was born in Moscow in 1961.

In 1984, she graduated from the Faculty of Pharmacy of the First Moscow Medical Institute (First Moscow State Medical University named after I.M. Sechenov). Since 1984, she graduated from the Faculty of Pharmacy at the I.M. Sechenov First Moscow State Medical University, where she subsequently held the positions of senior laboratory assistant (1984-1986), assistant (1986-1989), senior lecturer (1989-1993), associate professor (1993-2005), professor of the Department of Pharmacy Management and Economics of the Faculty of Pharmacy (2005-2006), head of the Department of Pharmacy Management and Economics (since 2007), dean of the Faculty of Postgraduate Professional Education for pharmacists (since 2005).
Expert in the field of management and economics of pharmacy, Doctor of Pharmacy, Professor.
She is the author of the first dissertation in marketing research on the pharmaceutical market in Russia, one of the founders and chief editors of a professional pharmaceutical magazine "LadyVita" (2003-2004).
Since 2005 she has been the editor-in-chief of the professional pharmaceutical magazine Pervy Stol.
Since 2007 she has been a member of the international pharmaceutical organization FIP.
By order of the Minister of Health of the Russian Federation, she was appointed Director of the Department of State Regulation of Circulation of Medicines.
In July 2013, she was appointed Assistant Minister of Health of the Russian Federation.
In October 2013, she was appointed Director of the Department of Drug Provision and Regulation of Circulation of Medical Products of the Russian Ministry of Health.
In 2020, she was appointed Head of the Federal State Institution "Federal Center for Planning and Organization of Drug Provision to Citizens".

Oleg Malakhov

Chairman of the Board of Directors, PRIMEKEY Group of Companies; member of the General Council, All-Russian public organization "Business Russia"

Nuria Musina

Director of Development, Health Technology Assessment Association

Thi Thu Thuy Nguyen

Dean, Pharmacy Faculty, Hong Bang International University

Front row participant
Alima Almadiyeva, Deputy Chairman of the Board, National Scientific Center for Health Development named after Salidat Kairbekova (online)

Alima Almadiyeva

Deputy Chairman of the Board, National Scientific Center for Health Development named after Salidat Kairbekova